Ai2 Limited is pleased to announce the appointment of Dr Duncan Henderson as R&D Manager With a licence deal signed for application of Ai2 peptide technology in this area Ai2 is now expanding its focus to other medical device applications and to areas outside the medical device sector including oral care, personal care and advanced wound care Since its foundation Ai2 has grown into a successful SME funded through private investment and grant funding with a strong IP portfolio